Exploring the Crosstalk Between Adipose Tissue and the Cardiovascular System
Author | : Nadia Akawi |
Publisher | : Frontiers Media SA |
Total Pages | : 106 |
Release | : 2022-09-27 |
Genre | : Science |
ISBN | : 2889767647 |
Download Exploring The Crosstalk Between Adipose Tissue And The Cardiovascular System full books in PDF, epub, and Kindle. Read online free Exploring The Crosstalk Between Adipose Tissue And The Cardiovascular System ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : Nadia Akawi |
Publisher | : Frontiers Media SA |
Total Pages | : 106 |
Release | : 2022-09-27 |
Genre | : Science |
ISBN | : 2889767647 |
Author | : Thiago Bruder |
Publisher | : Frontiers Media SA |
Total Pages | : 139 |
Release | : 2022-01-13 |
Genre | : Science |
ISBN | : 2889740528 |
Author | : Gianluca Iacobellis |
Publisher | : Springer Nature |
Total Pages | : 198 |
Release | : 2020-03-25 |
Genre | : Medical |
ISBN | : 3030405702 |
This book is the first authoritative and comprehensive volume dedicated to epicardial adipose tissue (EAT). It provides an up-to-date and highly illustrated synopsis of the anatomical, biomolecular, genetic, imaging features, and clinical applications of EAT and its role in cardiovascular disease. It relays to the reader a contemporary view of the emerging interplay between the heart and adiposity-related diseases. In addition, this volume discusses the clinical implications and therapeutic targets of EAT in atrial fibrillation, heart failure and coronary artery disease. Comprehensive yet focused, Epicardial Adipose Tissue: From Cell to Clinic is an essential resource for physicians, residents, fellows, and medical students in cardiology, endocrinology, primary care, and health promotion and disease prevention.
Author | : Gianluca Iacobellis |
Publisher | : Oxford University Press |
Total Pages | : 293 |
Release | : 2009-10-08 |
Genre | : Medical |
ISBN | : 019954932X |
This essential book comprehensively covers the diagnosis, treatment and management of cardiovascular disease in obese patients, translating up-to-date clinical research findings into clinical practice.
Author | : Juergen Eckel |
Publisher | : Academic Press |
Total Pages | : 242 |
Release | : 2018-06-12 |
Genre | : Science |
ISBN | : 0128097191 |
The Cellular Secretome and Organ Crosstalk focuses on the release of peptides and proteins from different organs and their specific functions in metabolic regulation and cell- and organ crosstalk. The book is written for experts in the field, however, for each topic, helpful references are included. The book also includes technical sections that summarize the state-of-the-art of secretome and crosstalk analysis. This book fulfills the need for a resource that comprehensively describes the current knowledge of secretome biology in health and disease. Communication between different organs involves lipids and other small molecules and a host of proteins and peptides comprising the secretome of different organs (organokinome). More than 600 adipokines have been identified, and an increasing number of hepatokines and myokines have recently been discovered with mostly unknown physiological impact. Importantly, an aberrant signature of the organokinome may be critically underlying a variety of metabolic diseases and may determine the individual susceptibility to disease development. - Summarizes our current knowledge on the secretome of different cells and tissues - Dissects auto-, para- and endocrine functions of major secreted peptides and proteins - Analyzes the secretory malfunction of different cells and its impact for disease development - Authored by a leader in the field, presenting a coherent view on this very complex topic
Author | : Todd Leff |
Publisher | : John Wiley & Sons |
Total Pages | : 530 |
Release | : 2010-03-19 |
Genre | : Science |
ISBN | : 9783527629534 |
This timely and most comprehensive reference available on the topic covers all the different aspects vital in the fight against the global obesity epidemic. Following a look at adipose tissue development and morphology, the authors go on to examine its metabolic and endocrine functions and its role in disease. The final section deals with comparative and evolutionary aspects of the tissue. The result is an essential resource for cell and molecular biologists, physiologists, biochemists, pharmacologists, and those working in the pharmaceutical industry.
Author | : Malcolm K Robinson |
Publisher | : CRC Press |
Total Pages | : 475 |
Release | : 2006-03-07 |
Genre | : Medical |
ISBN | : 1420018906 |
Although cardiovascular disease remains the leading proximate cause of death in the United States, it is now estimated that obesity may be equivalent to smoking as the leading cause of preventable death in America. In light of these statistics, this reference presents our current understanding of the epidemiology, pathology, and genetics of the obe
Author | : Naveed Sattar |
Publisher | : John Wiley & Sons |
Total Pages | : 64 |
Release | : 2009-04-08 |
Genre | : Medical |
ISBN | : 1444312707 |
Obesity is a hugely expensive and increasing problem worldwide,leading to disability, reproductive problems, depression andaccelerated metabolic and vascular diseases in a large proportionof men, women and children. The ABC of Obesity is a newguide which will aid its effective management, addressing issuessuch as dieting, exercise, self esteem, drug treatment and surgery.Recent evidence is used to highlight frequent problems, successfultreatment options, and the most common causes. Written by leading experts, this is a widely accessible text andan indispensable guide for all general practitioners, juniordoctors, nurses, and other healthcare professionals who areinvolved in the treatment and research of this commoncondition.
Author | : Matthias Clauss |
Publisher | : Springer Science & Business Media |
Total Pages | : 342 |
Release | : 2004-11-22 |
Genre | : Medical |
ISBN | : 9783764364595 |
Is it advisable to go back from bedside to the bench? During the last decade, few topics encountered such a broad interest in bio- gy and medicine as angiogenesis. The amazing ability of the body to restore blood flow by induction of blood vessel growth as part of an adaptive process has alarmed physicians dealing with diseases in which angiogenesis is either exaggerated (as in tumors) or too slow (as in ischemic diseases of heart and brain). Not surprisingly, pro- and antiangiogenic strategies have found their way into clinical trials. For instance, for the USA, the NIH website in early 2004 displayed 38 clinical studies involving either pro- or antiangiogenic th- apies. Given the expected overwhelming wealth of clinical data, the question may be asked whether further exploration of biological mechanisms is required or whether results from the bedside are instructive enough to proceed. This question depends also on the progress of pro- and antiangiogenic clinical trials. In the following, I give a short overview about some of the progress that has been made in this field. Since Judah Folkman proposed antiangiogenic tumor therapy thirty years ago, it has become increasingly evident that agents which interfere with blood vessel formation also block tumor progression. Accordingly, antiangiogenic therapy has gained much attention as a potential adjunct to conventional c- cer therapy.
Author | : Bruce Spiegelman |
Publisher | : Springer |
Total Pages | : 108 |
Release | : 2018-03-07 |
Genre | : Science |
ISBN | : 3319727907 |
The world is faced with an epidemic of metabolic diseases such as obesity and type 2 diabetes. This is due to changes in dietary habits and the decrease in physical activity. Exercise is usually part of the prescription, the first line of defense, to prevent or treat metabolic disorders. However, we are still learning how and why exercise provides metabolic benefits in human health. This open access volume focuses on the cellular and molecular pathways that link exercise, muscle biology, hormones and metabolism. This will include novel “myokines” that might act as new therapeutic agents in the future.